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Over the last decade many C-glycosylﬂavonoids have been
isolated and identiﬁed from a wide variety of plant species.
Natural C-glycosylﬂavonoids differ from O-glycosylﬂavonoids in
having their glycosyl moiety attached via the anomeric carbon
directly to the ﬂavonoid backbone, usually at the C-6 or C-8
position of the A ring (Table 1, Fig. 1). C-glycosylﬂavonoids have
additional biological activities and high stability to hydrolysis
in comparison with O-glycosylﬂavonoids. In a recent review,
Rauter et al.1 summarized some new C-glycosylﬂavonoids, providing
a brief introduction to their characterization, bioactivities and synth-
esis, and Talhi and Silva2 established a database of the natural
occurrence of C-glycosylﬂavonoids with 109 new structures updated
in 2011. These two reviews speciﬁcally focused on the characteriza-
tion and bioactivities of C-glycosylﬂavonoids from organic syntheses
or natural products, including their antioxidant, hepatoprotective, anti-
inﬂammatory, and antiviral effects. Here we address recent research
on both the pharmacological activities and SAR studies of the
C-glycosylﬂavonoids. C-glycosylﬂavonoids can be categorized into
3 types: type I includes the ﬂavone-containing C-glycosylﬂavonoids;
type II includes the isoﬂavone C-glycosylﬂavonoids; and type III
encompasses the ﬂavanone C-glycosylﬂavonoids. The archetypical
structures of the C-glycosylﬂavonoids with these different scaffolds
are shown in Table 1.2. Antioxidant activity
Free radicals have been noted as a cause of many diseases,
including forms of hepatitis, inﬂammation, cancer, diabetes mellitus,
and neurodegenerative diseases. C-glycosylﬂavonoids have been
shown to act as scavengers of various oxidizing species, including
superoxide anion (O2
−d), hydroxyl radical, and peroxy radicals.2.1. The sugar position
Isoorientin (1) and orientin (2) occur widely in plants, presenting
similar activities in the reduction of 1,1-diphenyl-2-picryl-hydrazyl
(DPPH) (IC50 values about 9–10 μM) or the inhibition of lipid
peroxidation3. The DPPH radical scavenging activity of vitexin (3)
and isovitexin (4) showed SC50 values of 129 and 325 μM,
respectively, while 1 (SC50¼31 μM) showed superoxide radical
scavenging activity similar to 2 (SC50¼38 μM)4. The sugar
position at C-6 or C-8 has no inﬂuence on the activity. Similar
results were obtained when comparing the antioxidant activity of
the four monoglycoside C-glucosides, with the order of the
antioxidant activity determined with 2,2′-azinobis-(3-ethyl-
benzothiazothiazoline-6-sulfonate) (ABTS) and DPPH as follows:
142c443. The order of the antioxidant activity determined
against superoxide anion radicals was 1≥244¼35. In addition to
the different antioxidant mechanisms of these compounds, 1 and 2
show signiﬁcantly higher antioxidant activity than 3 and 4, thus
clearly indicating that the antioxidant properties of these com-
pounds are mostly dependent on the free hydroxyl group in the B
ring of the compounds.
These results indicated that the substitution of C-glycosylﬂa-
vones at the C-6 and C-8 positions yields similar activities.
According to the differences between 1 and 2 (3 and 4), we
conclude that the free hydroxyl groups on the B ring to the
antioxidant properties of C-glycosylﬂavones is of the greatestimportance, with minor signiﬁcance attributed to the substitution
of glucose at the C-6 or C-8 position of the A ring.
2.2. The number of the sugar
Isoorientin (1), swertiajaponin (5) and isoorientin 2″-O-α-L-
rhamnoside (6), which were isolated from Cymbopogon citrates
(Poaceae) leaves, displayed remarkable antioxidant effects at low
concentrations. 1, the best antioxidant, has the sugar attached at C-
6, while 6, which has an additional sugar at C-6 position in
comparison with 1, had reduced antioxidant potency. The mono-
glycosylated ﬂavonoids 1 and 5 are more active against low
density lipoprotein (LDL) oxidation than the diglycosylated
ﬂavonoid 66. Five C-glycosylﬂavonoids, namely, 1, 2, 3, 4 and
7, were isolated from extracts of Mimosa pudica Linn., and 7 was
shown to have the greatest antioxidant activity. This result
suggested that antioxidant activity may be increased slightly with
the length of the carbon chain of sugar in ﬂavonoids7.
In summary, the antioxidant activity may be increased or
decreased slightly with the length of the carbon chain of the sugar
in ﬂavonoids, but the reasons have yet to be clariﬁed.
2.3. The number of the hydroxyl groups
Six C-glycosylﬂavonoids (1, 2, 3, 4, 8 and 9) and O-glycosyl-
ﬂavonoid 10 were isolated from the shoot system of Okinawa
Taumu (Colocasia esculenta S.). The IC50 values for inhibition of
superoxide radical activity are as follows: 1 (67 μM), 2 (171 μM),
3 (4500 μM), 4 (4500 μM), 8 (4500 μM), 9 (4500 μM), 10
(4500 μM). Thus, the antioxidant activities of the C-glycosyl-
ﬂavonoids were affected by the number of the hydroxyl groups on
the B ring of the aglycone. 1, 2 and 10 with two hydroxyl groups
have stronger antioxidant activities than the other ﬂavonoid
glycosides that have only one hydroxyl group on the B ring4.
Compounds 1, 5 and 11 presented activities toward the DPPH
with IC50 values of 9.1, 13.4 and 39.6 μM, respectively. As 5 and
11 have a methoxy groups at either the C-7 position of ring A or
the C-3′ position of ring B, this greater IC50 values for these two
compounds suggests that the methylated hydroxyl group of C-7
and the methoxylation at C-3′ reduced the antioxidant activity3.
In conclusion, the hydroxyl groups at the C-3′ and C-4′
positions of B ring or hydroxyl group at C-7 of A ring play a
key role in radical scavenging activity.
2.4. The substituent of sugar
The ﬂavone C-glycoside, 1 and 12, were isolated from an ethanol
extract of aerial parts of Clematis rehderiana. Compound 12 has one
hydroxyl group in the B ring, showing potent activity against H2O2-
induced impairment in PC12 cells within the concentration range tested
(0.4–50 μM), whereas 1 has two hydroxyl groups and scavenged the
DPPH radical strongly with an IC50 value of 13.5 μM, indicating that
12 might be an indirectly acting antioxidant, while 1 might be a
directly acting antioxidant8. Thus, it can be deduced that the addition of
a p-coumaroyl group to the sugar has less inﬂuence than a hydroxyl
group on the antioxidant activity of ﬂavonoids.
The in vitro antioxidant activities of ﬂavonoids have been
recognized for decades, and it is generally understood that compounds
with high radical-scavenging ability have lower absolute hardness and
absolute electronegativity. As to the C-glycoside, with glucose at C-6
or C-8 the antioxidant activity decreases due to steric hindrance by the
Table 1 Structures of ﬂavonoids with their corresponding numbering system.
Compd. Flavonoid-type R1 R2 R3 R4 R5 R6
1 I H Glc OH H OH OH
2 I H H OH Glc OH OH
3 I H H OH Glc H OH
4 I H Glc OH H H OH
5 I H Glc OCH3 H OH OH
6 I H Rha(1-2) Glc OH H OH OH
7 I H Api(1-4)Glc H H OH OH
8 I H Glc OH Ara H OH
9 I H Ara OH Glc H OH
10 I H Glc (1-2)GlcO OH H OH OH
11 I H Glc OH H OCH3 OH
12 I H R2(1)
a OH H H OH
13 I H Api OH Glc OH OH
14 I H Glc OH Glc H OH
15 I H Glc OH Glc OH OH
16 I H Xyl OH Glc H OH
17 I H H OH H H OH
18 I H Glc OH Xyl H OH
19 I H Glc OCH3 H H OH
20 I H H OCH3 Xyl(1-2)Glc OCH3 OH
21 I H H OCH3 Glc OCH3 OH
22 I H Fuc OH H H OH
23 I H Rha(1-2)Fuc OH H H OH
24 I H H OH Glu(1-2)Glc H OH
25 I H H OH Rha(1-2)Glc H OH
26 I H H OH H OH OH
27 I H Glc CH3O H H OGlc
28 I H Ara OGlc H OH OH
29 I H GalUA(1-2)Ara OH H H OH
30 I H GalUA(1-2)Ara OH H OH OH
31 I H GlcUA(1-2)Ara OH H OH OH
32 I H Glc OGlc H OH OH
33 I H Rha(1-2) Glc OH H OH OCH3
34 I H R2(2)
a OH H H OH
35 I H R2(3)
a OH H H OH
36 I H H OCH3 R4(1)
a OH OH
37 I H H OCH3 R4(2)
a OH OH
38 I H H OCH3 R4(1)
a H OH
39 I H H H Gal(1-2)Glc H OH
40 I OH Glc OH H OH OH
41 I OH Glc OH H H OH
42 I H Glc(1-2) Glc OCH3 H H OH
43 I H Glc OH Glc H H
44 I H H OCH3 Rha(1-6) Glc H OH
45 I H H OCH3 Rha(1-2) Glc OH OH
46 I H H OCH3 Glc H OH
47 I H H OCH3 Boi OH OH
48 II H H OH Glc H OH
49 II H H OH Glc OCH3 OH
50 III OH Glc OH H OH OH
51 III H Glc OH H H OH
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Table 1 (continued )
Compd. Flavonoid-type R1 R2 R3 R4 R5 R6
52 III OH Glc OH H H OH
53 III H Glc OH H OH OH
aStuctures of the C-glycosylﬂavonoids group R2, R4. Please see Fig. 1.
Figure 1 Structures of the C-glycosylﬂavonoids group R2, R4 and most common sugars in C-glycosylﬂavonoids.
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Figure 2 Proposed metabolic pathways of isoorientin (1) degradation initiated by the gut microﬂora.
P. Zeng et al.158glucose moiety. Substitution of glucose on the A ring, the number of
sugars, and the substituents on the sugar may also affect antioxidant
activity. Therefore, hydroxyl groups in the structure of ﬂavonoids are
the key factors for antioxidant activity. Recently, the SAR based on the
chemical hardness theory indicated that hydroxyl groups at the C-3′
and C-4′ positions of B ring or a hydroxyl group at C-7 of the A ring
strikingly decrease the absolute hardness of ﬂavones, which have high
scavenging activity9.
These SAR studies showed that the in vitro antioxidant activity
of C-glucosides is similar to the O-glucosides. However, few
studies have been performed on the antioxidant activity of
C-glucosides in vivo. Zhang et al.10 discussed the metabolism of
ﬂavone C-glucosides obtained from “antioxidant of bamboo
leaves” (AOB) in rats: with a single oral administration of AOB,
the four ﬂavone C-glucosides 1, 2, 3 and 4 from AOB were poorly
absorbed in the gastrointestinal tract. More than 50% of the
ﬂavone C-glucosides were recovered at 12 h in the gastrointestinal
tract, which suggested that the passage time for these compounds
in colon is long enough to exert their antioxidant activity and to
scavenge free radicals. In addition to excretion in their original
forms, the ﬂavone C-glucosides were also hydrolyzed into their
aglycones and degraded into small-molecule phenols and various
aromatic acids (Fig. 2).3. Hepatoprotective effects
Several C-glycosylﬂavonoids have been shown to have hepatopro-
tective effects. The methanolic extract of the stems of Montanoa
bipinnatiﬁda was investigated for its phenolic compounds and
hepatoprotective activity, which was able to prevent a CCl4-induced
rise in serum enzymes. Seven C-glycosyl ﬂavonoids, 1, 2, 3, 4,
luteolin 6-C-apioside-8-C-glucoside (13), apigenin 6,8-di-C-gluco-
side (14), and luteolin 6,8-di-C-glucoside (15) were isolated from a
M. bipinnatiﬁda stems aqueous alcoholic extract11.
Isoschaftoside (9) and other 4 trisaccharide ﬂavonols were
isolated from green tea. These compounds suppressed the
D-galactosamine-induced increase of plasma ALT and AST activities
in rats, indicating that they have a liver injury suppressing effect12.
Sasa borealis (Poaceae) is a perennial medicinal plant in Korea,
and the n-BuOH extract of S. borealis leaves exhibited signiﬁcant
antioxidant activity against DPPH radical and a cytoprotective effect
against oxidative damage in HepG2 cells. Bioactivity-guided fractio-
nation by column chromatography led to the isolation of three
ﬂavonoid C-glycoside derivatives, compounds 1, 6 and 16. 1 and 6
showed potent free radical scavenging activity and a strong cytopro-
tective effect against t-BuOOH-induced oxidative damage in HepG2cells, at the very low concentrations of 1.1 and 0.8 μM, respectively,
while 16 showed marginal radical scavenging activity13. SAR studies
for the antioxidant efﬁcacy of ﬂavonoids have provided evidence that
lacking the hydroxyl groups at C-3′ of the B ring shows no effect on
cytoprotective potential.
Puerarin (48), a major isoﬂavonoid compound isolated from
Pueraria lobata, could effectively reverse chemical-induced liver
ﬁbrosis in experimental rats14.
Compounds 8, 9 and 14 were isolated from Abrus cantoniensis
and Abrus mollis. Hepatoprotective effects were investigated
against immunological liver injury induced by CCl4, LPS and
alcohol in mice, showing that these compounds have strong
cytoprotective effects on liver injury, better than the positive
control diammonium glycyrrhizinate at the same concentration15.
Compounds 4 (C-glycosyl) and other O-glycosylﬂavonoids were
isolated from Lespedeza cuneata. The ethanol extract of the plant at
a dose of 20 μg/mL signiﬁcantly protected HepG2 cells against the
cytotoxicity of t-BHP. While 4, which has one hydroxyl group in
the ﬂavone structure, showed no protective effect against t-BHP
injury in HepG2 cells in the assays, other O-glycosylﬂavonoids
exhibited clear hepatoprotective activity16.
A number of reports17–19 have shown a correlation between
antioxidative activity and hepatoprotective effects of ﬂavonoids.
The protective effects of ﬂavonoids on human liver-derived HepG2
cell line injured by drugs such as t-BHP and CCl4 are highly
correlated with the antioxidant properties of the ﬂavonoid. Sponta-
neous or induced oxidative stress was found to cause liability of cell
membranes, suggesting that radical scavenging activity has a
signiﬁcant inﬂuence on the cytoprotective effectiveness against t-
BHP injury. Therefore, C-glycosylﬂavonoids have considerable
antioxidant activity, which should also have hepatoprotective effects.4. Anti-inﬂammatory activity
There have been many bioassay-guided searches of C-glycosyl-
ﬂavonoids for anti-inﬂammatory activity in plants, and especially
those known to be used in folk medicine.
Dendrobium huoshanense (Orchidaceae) was claimed to have
anti-inﬂammatory activities in traditional Chinese medicinal prac-
tice. The ethanol- or methanol-soluble fractions of the extract can
inhibit the expression of tumor necrosis factor-α (TNF-α) and
other inﬂammatory cytokines in lipopolysaccharide (LPS)-acti-
vated RAW264.7 cells, which later was shown to contain 6,8-di-
C-glycosyl ﬂavonoids. Regarding 1 that has a glucose moiety on
the apigenin (17) scaffold, its IC50 for TNF-α expression improved
from 18.5 μM (for apigenin) to 9.7 μM. Compound 14, whose
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enhanced potency up to an IC50 value of 6.8 μM20. This study
indicated that glucosyl moieties improve the anti-inﬂammation
activities.
The three ﬂavone C-glycosides 14, 16 and 18 were isolated
from Selaginella moellendorfﬁi Hieron. The in vitro bioassay for
14 showed moderate inhibition in a concentration-dependent
manner (12.5–50 μg/mL) against induction of COX-2 mRNA
expression21.
The ability of the ethanolic extracts of Achillea ligustica All.
(Asteraceae) ﬂowering tops to inhibit non-enzymatic lipid perox-
idation was studied using a simple in vitro system of linoleic acid
oxidation, and the extracts exerted a protective effect at the lowest
amount tested (5 μg). Protection on Caco-2 intestinal cells against
tert-butyl hydroperoxide (TBH)-induced toxicity showed that the
extracts have the ability to protect against oxidative stress induced
by TBH starting from concentrations as low as 10 μg/mL. The
C-glycosylﬂavonoid 8 was isolated from the extracts22.
Chafuroside A (Fig. 3), a poorly water-soluble ﬂavone C-glycoside,
was isolated from oolong tea, and showed potent anti-inﬂammatory
activity. Using a self-assembled micellar system to develop a water-
soluble formulation, the therapeutic potential of Chafuroside A was
noted for the treatment of inﬂammatory diseases23.
Four ﬂavone C-glycosides (1, 2, 3 and 4) were isolated from the
neotropical blueberry Anthopterus wardii. A dose–response rela-
tionship of compounds 1–4 was observed for their anti-
inﬂammatory activity against interleukin-8 (IL-8) and for the
inhibition of matrix metalloproteinase-1 (MMP-1) expression.
All the 4 ﬂavone C-glycosides exhibited inhibitory activity against
IL-8 production and MMP-1 expression, with 1, 3 and 4 having
the most potent inhibitory activities in both assays at 100 μg/mL24.
The RAW264.7 cells incubated with 4 had markedly reduced
lipopolysaccharide (LPS)-stimulated NO production with an IC50
value of 58.5 μM. The expression of nitric oxide synthase (iNOS)
was also inhibited when the cells were treated with 4, showing that
4 suppresses the iNOS promoter and NF-κB-dependent transcrip-
tional activities25.
Huang et al.26 reported that 4 inhibits the release of TNF-α
upon LPS activation with an IC50 of 78.6 μM, and markedly
reduces LPS-stimulated PGE2 production in a concentration-
dependent manner, with an IC50 of 80.0 μM.
de Melo et al.27 reported that 8 and 3, isolated from the aerial
parts of Eleusine indica Gaertn (Poaceae), cause a signiﬁcant
decrease in lung neutrophil inﬂux in mice exposed to LPS.
The extract of Cayaponia tayuya roots was identiﬁed as a
mixture of ﬂavonoids 4, 5, 14 and 19. In acute TPA-induced
edema in mouse ears, the ﬂavonoid-enriched fraction (at a dose of
0.5 mg/ear) inhibited the edema by 66% while in the subchronic
model the inhibition reached 37% at a dose of 0.5 mg/ear 7
applications. These results indicate that the anti-inﬂammatoryFigure 3 Structure of Chafuroside A.activity of ﬂavonoids most likely stems from their inhibition of
the induction of the enzymes COX-2 and iNOS28.
Five ﬂavone C-glycosides 2, 5, 6, 20 and 21 were isolated from
Callicarpa kwangtungensis Chun. The preliminary anti-inﬂammatory
assays showed that 2, 5 and 6 have signiﬁcant in vitro anti-
inﬂammatory activity, each of which has a hydroxyl group at the 3′-
and 4′-positions of B ring and 7-position of A ring, whereas 20 and 21
have methoxy groups at 3′-positions of B ring and 7-position of A ring,
respectively. The difference between these structures may imply that
the anti-inﬂammatory activity of the compounds was affected by the
number of the hydroxyl groups at the A and B ring29.
In summary, in addition to the described different anti-inﬂammatory
mechanisms of action of these C-glycosylﬂavonoids, we found that the
glucosyl moieties and hydroxyl groups at the 3′- and 4′-positions of the
ﬂavonoid B ring may improve the anti-inﬂammatory activities.5. Antidiabetics activities
Two isoﬂavone C-glucosides, puerarin (48) and 3-methoxypuerarin
(49) were isolated from a MeOH extract of the roots of Pueraﬁa
iobata. The two isoﬂavone C-glucosides showed more potent
in vitro inhibitory activity against advanced glycation end products
(AGEs) formation than the positive control—aminoguanidine30.
Compounds 3 and 4 were puriﬁed and identiﬁed as two major
phenolics of the anti-glycation activity of four kinds of beans
including mung bean, black bean, soybean and cowpea. In the
anti-glycation assays, both 3 and 4 showed signiﬁcant inhibitory
activities against the formation of AGEs induced by glucose or
methylglyoxal with efﬁcacies of over 85% at 100 μM. In another
assay, 3 and 4 failed to directly trap reactive carbonyl species, such
as methylglyoxal, suggesting that their anti-glycation activities
may be mainly due to their free radical scavenging capacity31.
Apigenin-6-C-β-L-fucopyranoside (22) and apigenin-6-C-(2″-O-α-
rhamnopyranosyl)-β-fucopyranoside (23), isolated from Averrhoa
carambola L. (Oxalidaceae), showed an ability to acutely lower
blood glucose in hyperglycemic rats and enhance glucose-induced
insulin secretion. A stimulatory effect of 22 on glycogen synthesis
was observed when muscles were incubated with this ﬂavonoid and
its effect was completely nulliﬁed by pre-treatment with insulin
signal-transduction inhibitors. Taking this into account, the MAPK–
PP1 and PI3K–GSK3 pathways appear to be involved in the
apigenin-6-C-β-L-fucopyranoside-induced increase in glycogen synth-
esis in muscle. The results provide evidence for dual effects of 22 as
an antihyperglycemic (insulin secretion) as well as an insulinomi-
metic (glycogen synthesis) agent. Furthermore, both ﬂavonoids
reduced serum glucose levels after acute treatment and appear to
manage glucose utilization through different pathways32,33.
A crude extract of Wilbrandia ebracteata roots reduced
glycemia and increased glycogen content and serum insulin in
hyperglycemic rats. The C-glycosylﬂavones 4 and 5 isolated
from the extract showed a strong antihyperglycemic action com-
pared with the extracts. These results suggested that the isolated
C-glycosylﬂavones have antihyperglycemic function that was
reinforced by stimulation of in vivo insulin secretion34.
Three C-glycosylﬂavones [vitexin-2″-O-glucoside (24), vitexin-
2″-O-rhamnoside (25) and 3] and O-glycosylﬂavones [quercetin-3-
O-rha-(1-4)-glc-rha] were isolated from hawthorn leaf. Several
other C-glycosylﬂavones 1, 2, 4 and their aglycones 17 and 26
were evaluated by in vitro assays. All six tested compounds
showed higher α-glucosidase inhibitory activity than acarbose, one
of the most potent α-glucosidase inhibitor drugs. The inhibitory
P. Zeng et al.160activity decreased in the following order: 2641≥144
24443, indicating that ﬂavones with a hydroxyl group at C-3′
possessed stronger inhibition than the corresponding ﬂavones
without a C-3′ hydroxyl group. Moreover, the aglycones showed
stronger activity than their respective C-glycosylated derivatives:
the inhibition rate followed the order of 264142. Glycosylation
at C-8 weakened the inhibitory activity of ﬂavones against
α-glucosidase, as the inhibition rates were 443 and 142. Based
on the activities of these ligands, similar C-glycosylﬂavones and
corresponding aglycones were evaluated using in vitro assays; the
5,7,4′-trihydroxyﬂavone structure, such as in apigenin and luteolin
derivatives, was crucial for the inhibitory activity, but an addi-
tional C-3′–OH substitute on the B-ring enhanced the activity. On
the other hand, C-glycosylations at C-8 weakened the inhibition35.
The C-glycosylﬂavones 1, 2, 3, 4, 5, 27 and other O-glycosyl-
ﬂavonoids were isolated from the aerial parts of Commelina
communis L. While 3 and 5 inhibited α-glucosidase activity from
rat intestine, other constituents did not show this activity36.
These studies provide evidence that the potential anti-glycation
activity of C-glycosylated ﬂavones may have high correlation with
the antioxidant properties of the ﬂavonoid. C-glycosyl ﬂavone
with sugar moieties at C-6 or C-8 weakened the potency.6. Antiviral activity
C-glycosylﬂavones also exhibit useful antibacterial activity. The
in vitro anti-herpes effects of the crude aqueous extract obtained
from Cecropia glaziovii leaves and their related fractions, the
n-butanol fraction (n-BuOH) and the C-glycosylﬂavonoid-
enriched fraction (MeOHAMB) were investigated, and showed that
the MeOHAMB fraction has an antiviral activity against HHV types
1 and 2. The C-glycosylﬂavonoids are the major constituents
of this fraction, which suggests that they could be one of the
components responsible for the detected anti-herpes activity37.
Seven ﬂavone C-glycosides [2, 5, luteolin 6-C-α-L-arabinopyr-
anosyl-7-O-β-D-glucopyranoside (28), apigenin 6-C-β-D-galacto-
pyranosiduronic acid (1-2)-α-L-arabinopyranoside (29), luteolin
6-C-β-D-galactopyranosiduronic acid (1-2)-α-L-arabinopyrano-
side (30), luteolin 6-C-β-D-glucopyranosiduronic acid (1-2)-α-
L-arabinofuranoside (31) and luteolin 6-C-glucopyranosyl-7-O-β-D-
glucopyranoside (32)] were isolated from the leaves of Lophatherum
gracile. All the ﬂavone glycosides isolated from this plant and
monoglycosides (1, 3, 4 and 5) were screened for in vitro antiviral
activity against respiratory syncytial virus (RSV) with the cytopathic
effect (CPE) reduction assay. The four ﬂavone 6-C-monoglycosides
displayed anti-RSV activity to differing extents with IC50 values ranging
from 5.7 to 50 μg/mL. Notably, ﬂavone 6-C-monoglycosides 1 and 4
showed potent anti-RSV activity with selectivity index values higher
than that of ribavirin. In contrast, other ﬂavone C-glycosides including
ﬂavone 8-C-monoglycosides, ﬂavone 6-C-diglycosides, and ﬂavone 6-
C-glycosyl-7-O-glycosides did not show an anti-RSV effect38.
The ﬂavone C-diglycoside 6 and isoswertisin-4″-methoxy-
ether-2″-α-L-rhamnoside (33) along with other compounds were
isolated from the leaves and stems of Peperomia obtusifolia
(Piperaceae). These ﬂavones were evaluated by bioautographic
assay against Cladosporium cladosporioides and Cladosporium
sphaerospermum and showed weak antifungal activity39.
Three C-glycosylﬂavones (4, 34 and 35) isolated from Clidemia
sericea showed moderate activity (2471, 3872, and 4471 μM,
respectively) against Plasmodium falciparum strain (chloroquine-resistant). Additionally, 34 and 35 were more active than 4,
suggesting that the galloyl moiety is necessary for the activity40.
The C-glycosylﬂavones trollisin I (36), trollisin II (37), 2″-O-
(2″-methylbutanoyl) isoswertisin (38) and vitexin galactoside (39),
which were isolated from Trollius chinensis, were screened for
antiviral activity. Only 38 showed moderate in vitro antiviral
activity against inﬂuenza virus A with an IC50 value of 74.3 μg/mL.
The preliminary SAR study was performed on the basis of in vitro
antiviral activities. The structural difference between 36 and 38 is
the presence/absence of the 3′-OH group, respectively. Since 36 is
inactive, an hydroxyl group function at C-3′ seems to be a dis-
advantage in terms of antiviral activity. Also, the 7-OH group and
the different sizes of 38 and 39 may be additional limiting factors in
antiviral activity41.7. Other biological activities of C-glycosylﬂavonoid
7.1. Antibacterial activities
Four glycosylﬂavones (1, 2, 3 and 4) were isolated and identiﬁed
from L. gracile Brong. The results showed that the compounds
have some antibacterial activities against Staphylococcus aureus42.7.2. Alkaline phosphatase activity
Chemical investigation of Ulmus wallichiana stem bark resulted in
the isolation and identiﬁcation of seven known ﬂavonoid-6-C-
glucosides. Compounds 40 and 50–52 signiﬁcantly stimulated
osteoblast ALP activity compared with control (vehicle), while
compounds 1, 41 and 53 exhibited neither stimulatory nor
inhibitory effect on osteoblast ALP activity. It was observed that
the ﬂavonoid-6-C-glucosides (50) and 52 possessing the (2S, 3S)
stereochemistry and 51 possessing the (2S) stereochemistry are
important units for eliciting osteogenic activity. The ﬂavone 6 and
ﬂavanone 52 have the same OH substitutions, but 6 was found to
be inactive while 52 was active. It seems that the alkaline
phosphatase activity is dependent upon stereochemistry. Further-
more, it seems that the hydroxyl at C-3 or C-3′ is not important for
activity as 1, 41 and 53 were found to be inactive while 40, 50 and
51 were active43.7.3. Neuropharmacological activity
The extracts from Passiﬂora edulis ﬂavicarpa possess anxiolytic-
like and sedative properties, but not anticonvulsant activity. Thin
layer chromatography and high-performance liquid chromato-
graphic analysis indicated the predominance of C-glycosylﬂavo-
noids in these extracts and fractions, which were identiﬁed as 1,
14, spinosin (42), and 6,8-di-C-glycosylchrysin (43)44.7.4. Nematicidal activity
Arisaema erubescens (Wall.) Schott tubers possesses signiﬁcant
nematicidal activity against the root-knot nematode (Meloidogyne
incognita). From the ethanol extract two nematicidal ﬂavone-C-glyco-
sides 8 and 9 were isolated by bioassay-guided fractionation. Both
compounds show strong nematicidal activity against M. incognita
(LC50¼114.66 μg/mL and 323.09 μg/mL, respectively)45.
Advances in studying of the pharmacological activities and structure–activity relationships of natural C-glycosylﬂavonoids 1617.5. Inhibition of urease activity
Seven C-glycosylﬂavonoids were isolated from the n-butanol-
soluble fraction of Celtis africana. These are 2, 4, 19, 25, celtisides
A (44), celtisides B (45) and isoswertiajaponin (46). The inhibitory
activity of these compounds against urease was determined by the
method used by Weatherburn. The compounds 2, 4, 19 and 46
were potent urease inhibitors with IC50 values of 35, 28, 38 and
43 μM, respectively, as compared to the IC50 value of 21.5 μM
observed for thiourea, a positive control. Compounds 25, 44 and
45 did not show pronounced activity. It is evident that the ability
to inhibit urease is decreased by the incorporation of an additional
sugar moiety46.
7.6. Anti-cataract activity
The occurrence of relevant amounts of ﬂavonoid glycosides,
particularly C-glycosides from Apis mellifera honey including
stingless bee honey could be associated with their putative anti-
cataract properties47.
7.7. Inhibition of pancreatic lipase activity
The C-glycosidic ﬂavone compounds 1, 2, 6, 25, luteolin 8-C-β-D-
boivinopyranoside (47), as well as other compounds were isolated
and identiﬁed from the leaves of Eremochloa ophiuroides. Among
the isolates, C-glycosidic ﬂavones showed the highest inhibitory
effects on pancreatic lipase. Looking at the position and number of
glycosyl groups on the ﬂavone skeleton for pancreatic lipase
inhibitory activity, it was found that the inhibitory potency of
luteolin, which does not have a C-glycosyl group on the A ring of
its ﬂavonoid moiety, was much weaker than that of ﬂavones with
C-glycosylated derivatives on their A ring. Furthermore, the
C-glycosylated ﬂavone at C-8 was more potent than a C-6
glycosylated ﬂavone. The C-glycosyl ﬂavone with two sugar
moieties at the C-6 position of the A ring showed especially potent
activity (IC50¼18.572.6 μM) when compared to the other tested
compounds48. The presence of at least one C-glycosylated sugar
moiety at the 6 or 8-position of the A ring is essential for the
inhibitory activity of the luteolin skeleton. The C-glycosylated sugar
number and attached position in the A ring appear to be particularly
important for strong inhibitory activity.8. Conclusions
The wide distribution of the natural C-glycosylﬂavonoid compounds in
a large variety of plant species has been described, and the wide range
of C-glycosylﬂavonoid biological activities has been summarized in
this review. The pharmacological activities of C-glycosylﬂavonoids are
similar to those of the O-glycosylﬂavonoids, and are mainly focused on
antioxidant activities, hepatoprotective, anti-inﬂammation, antiviral,
anti-glycation and anti-hyperglycemic effects. It is also noted that
C-glycosides differ from O-glycosides: C-glycosyl ﬂavones with sugar
moieties at C-6 or C-8 positions weakens the inhibition of anti-
glycation activity, however, the C-glycosylated sugar number and the
position of attachment appear to be particularly important for strong
pancreatic lipase inhibition. C-glycosylﬂavonoids are poorly absorbed
in the gastrointestinal tract, suggesting that the effective time of these
compounds in the colon should be long enough so that they can exert
their pharmacological effect. To integrate new knowledge of thepharmacological activities and SAR results of the natural C-glycosyl-
ﬂavonoids into human medicine, future research should (i) investigate
the precise SAR of the C-glycosylﬂavonoids with regard to hepato-
protective, anti-inﬂammatory, antiviral, anti-glycation and anti-hyper-
glycemic activities; (ii) establish the SAR of ﬂavones, isoﬂavones and
ﬂavanones; (iii) investigate the pharmacokinetics of these compounds
in relationship to their structure; (iv) delineate the differences in
the pharmacological activities between the C-glycosylﬂavonoids and
O-glycosylﬂavonoids; and (v) determine the most efﬁcacious approach
for enhancing the dissolution behavior of the poorly water-soluble
C-glycosylﬂavonoids.References
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